Welcome to our dedicated page for METTLER TOLEDO INTERNATIONAL INC/ SEC filings (Ticker: MTD), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Our SEC filing database is enhanced with expert analysis from Rhea-AI, providing insights into the potential impact of each filing on METTLER TOLEDO INTERNATIONAL INC/'s stock performance. Each filing includes a concise AI-generated summary, sentiment and impact scores, and end-of-day stock performance data showing the actual market reaction. Navigate easily through different filing types including 10-K annual reports, 10-Q quarterly reports, 8-K current reports, proxy statements (DEF 14A), and Form 4 insider trading disclosures.
Designed for fundamental investors and regulatory compliance professionals, our page simplifies access to critical SEC filings. By combining real-time EDGAR feed updates, Rhea-AI's analytical insights, and historical stock performance data, we provide comprehensive visibility into METTLER TOLEDO INTERNATIONAL INC/'s regulatory disclosures and financial reporting.
Mettler-Toledo International (MTD) director reported insider activity on 11/11/2025. The filing shows acquisition of 63 shares of common stock at $0, increasing directly held shares to 183. The reporting person also lists 1,628 shares held indirectly by a living trust. In addition, a stock option grant for 162 shares was reported with a $1,445.06 exercise price, expiring on 11/11/2035. The options vest in two equal annual installments beginning on the first anniversary of the grant, with first exercisability on 11/11/2026.
Mettler-Toledo International Inc. (MTD) reported insider activity by a director. On 11/10/2025, the director exercised 474 stock options at $595.31 per share and sold 474 common shares at $1,433.57 per share on the same day.
On 11/11/2025, the director acquired 63 common shares at $0 and received a new stock option grant covering 162 shares with a $1,445.06 exercise price. These options are first exercisable on 11/11/2026 and expire on 11/11/2035, vesting annually in two equal installments beginning on the first anniversary of the grant. Following the transactions, direct common stock holdings were 374 shares, and 162 options were beneficially owned.
Mettler-Toledo International (MTD) reported a director’s Form 4 showing equity awards on 11/11/2025. The filing lists the acquisition of 63 shares of common stock at a reported $0, bringing directly held common shares to 295 after the transaction. It also records a grant of stock options for 162 shares with an exercise price of $1,445.06. These options begin to vest in two equal annual installments starting on the first anniversary of the grant, are first exercisable on 11/11/2026, and expire on 11/11/2035. Following the grant, 162 options are beneficially owned.
Mettler-Toledo International Inc. (MTD) reported a director’s equity transactions. On 11/11/2025, the director acquired 157 shares of common stock at $0, bringing direct holdings to 732 shares. The director also received a stock option for 410 shares at an exercise price of $1,445.06. The option vests in two equal annual installments beginning on the first anniversary of the grant, becomes exercisable starting 11/11/2026, and expires on 11/11/2035.
Mettler-Toledo International Inc. (MTD) reported an insider transaction on Form 4 for its Chief Financial Officer. On 11/07/2025, the CFO acquired 1 share of common stock at $0, tied to a three-year performance period that was certified on that date; the shares are scheduled to be delivered upon vesting in January 2026.
After this transaction, the officer beneficially owns 5,096 shares, held directly. This filing reflects routine equity compensation mechanics rather than an open‑market purchase.
Mettler-Toledo International (MTD) reported an insider transaction on a Form 4. An officer (Head of Eur & NA Market Orgs) acquired 1 share of common stock on 11/07/2025, transaction code A, at a price of $0. Following the transaction, the officer beneficially owned 187 shares, held directly.
According to the footnote, the 1 share represents stock earned for a three-year performance period certified on November 7, 2025, with shares to be delivered upon vesting in January 2026.
Mettler‑Toledo International Inc. (MTD) disclosed an insider equity change by its President and CEO. On November 7, 2025, the executive was credited with 3 shares of common stock, coded as an acquisition. The filing notes these shares were earned for a three‑year performance period certified on that date and are scheduled to be delivered upon vesting in January 2026.
Following this transaction, the executive’s direct beneficial ownership stands at 3,094 shares.
Mettler-Toledo International Inc. (MTD): Form 144 filed for a proposed sale of 474 common shares through Merrill, with an aggregate market value of 679,512. The shares are listed on the NYSE, and the filing lists an approximate sale date of 11/10/2025.
The securities were originally acquired via stock option exercise on 11/08/2018. The filing notes 20,428,445 shares outstanding. This notice indicates an intended sale under Rule 144 and does not register new securities.
Mettler-Toledo International (MTD) disclosed a new director’s Form 3 effective 11/06/2025. The filing reports that no securities are beneficially owned. This initial Section 16 statement establishes the insider’s baseline holdings at zero and confirms the role as Director.
Mettler-Toledo International Inc. reported higher Q3 2025 results. Total net sales were $1,029,699 thousand versus $954,535 thousand in Q3 2024, led by Product revenue of $766,648 thousand and Service revenue of $263,051 thousand. Gross profit rose to $609,456 thousand, while operating costs increased, including research and development of $51,143 thousand and selling, general and administrative of $248,391 thousand.
Profitability improved modestly in the quarter. Net earnings were $217,493 thousand versus $211,516 thousand, with diluted earnings per share of $10.57 versus $9.96. For the nine months, total net sales were $2,896,664 thousand versus $2,827,234 thousand, and net earnings were $583,428 thousand versus $610,839 thousand, with diluted earnings per share of $28.12 versus $28.55.
Cash from operating activities reached $730,187 thousand for the nine months. The company repurchased $656,246 thousand of common stock (542,416 shares at an average price per share of $1,209.84). Long-term debt was $2,146,249 thousand as of September 30, 2025. The company closed several Q3 acquisitions with initial cash payments of $72,600 thousand and recorded $48,400 thousand of goodwill.